ACX-362E

CAS : 1275582-97-2

Ref. 3D-ABC58297

Informations sur le produit

• Nom: ACX-362E

Description

ACX-362E is a new drug that has been developed for the treatment of infectious diseases. This drug has been shown to inhibit the protein synthesis of bacteria and inhibit the replication of dna. ACX-362E also has a safety profile that is similar to other antibiotics and it can be administered orally. The drug also displays synergistic effects when used in combination with other drugs. The efficacy of this drug has been tested in clinical trials and it has shown promising results for treating a variety of infectious diseases, such as those caused by Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, or Enterobacter cloacae.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 423.3 g/mol
• Formule: C₁₈H₂₀Cl₂N₆O₂
• Degré de pureté: Min. 95%